Moderna gains after lifting annual revenue growth view

Moderna expects total revenue growth of 15% to 25% in 2026, up from its previous outlook of up to 10%. Third-quarter revenue was $1.3 billion, above analysts’ $885.1 million estimate, and the company reported net income of $162 million.